Cell Injury and Death

• Definition: Cell injury is the state that results when adaptive capacity (hypertrophy, atrophy, hyperplasia, metaplasia) is exceeded by an insult. It is reversible while ATP depletion is mild and membranes remain intact, and irreversible once membrane integrity and mitochondrial function are lost — at which point the cell dies by necrosis, apoptosis, or a regulated variant such as pyroptosis, necroptosis, or ferroptosis.
• Why it matters: Cell death is the final common pathway of nearly every organ-based disease tested on Step 1 and Step 2 CK. The clinical syndrome — chest pain with troponin release, focal neurologic deficit, transaminases in the thousands, oliguric acute kidney injury — is simply the anatomic address of dying cells plus the biochemical debris they spill.
• Time to irreversibility is organ-specific and reflects reliance on oxidative phosphorylation:
• Neurons: irreversible after only a few minutes of complete ischemia; hippocampal CA1, Purkinje cells, and neocortical layers 3/5/6 are the most vulnerable.
• Cardiac myocytes: irreversible injury begins after roughly 20–30 minutes of coronary occlusion, which is the entire rationale for door-to-balloon metrics.
• Renal tubular epithelium (proximal tubule, thick ascending limb) and hepatocytes (zone 3, centrilobular) follow; fibroblasts and skeletal muscle are relatively resistant.
• Epidemiology worth recalling: Ischemic cell death drives the leading causes of death in the United States — coronary heart disease first, with stroke also among the top causes. Acetaminophen toxicity is the most common cause of acute liver failure in the U.S. (AASLD acute liver failure guidance). Ischemic acute tubular necrosis and sepsis account for the majority of hospital-acquired AKI (KDIGO).
• Who the stem names: older adults with atherosclerotic risk factors, trauma/crush victims, sepsis and shock patients, overdose patients, and transplant recipients (reperfusion of a cold-ischemic graft).

Grouped by mechanism

• Hypoxia versus ischemia: Hypoxia (anemia, CO poisoning, high altitude, hypoventilation) impairs oxidative phosphorylation only. Ischemia additionally halts glucose delivery and waste removal, so anaerobic glycolysis cannot be sustained — ischemia therefore injures cells faster and more severely than hypoxia. Examiners test this contrast directly.
• Free radical/oxidative injury: reperfusion after ischemia, ionizing radiation (radiolysis of water yields hydroxyl radical), hyperoxia, and drug metabolism. Carbon tetrachloride is converted by hepatic CYP2E1 to the CCl3 radical; acetaminophen is converted to NAPQI, which depletes glutathione. Free iron and copper propagate injury through the Fenton reaction.
• Chemical/toxic: cyanide and CO (block cytochrome c oxidase / hemoglobin binding), heavy metals, ethanol, chemotherapeutics.
• Infectious and immunologic: bacterial exotoxins and endotoxin-driven pyroptosis, viral cytopathic effect, cytotoxic T cells and complement (perforin/granzyme and Fas–FasL, immune-complex fibrinoid necrosis).
• Physical: trauma, crush, burns, extremes of temperature, electrical injury, barotrauma.
• Nutritional/metabolic: protein-calorie malnutrition, thiamine deficiency, and lipid or glycogen overload.
• Genetic: enzyme deficiencies and storage diseases; G6PD deficiency removes NADPH-dependent glutathione regeneration; hereditary hemochromatosis supplies catalytic iron.

Modifiable risk factors

• Atherosclerotic drivers: smoking, hypertension, diabetes, dyslipidemia, obesity, physical inactivity — these determine who develops ischemic necrosis (ACC/AHA primary prevention framework).
• Exposures: alcohol, supratherapeutic or chronically therapeutic-high acetaminophen with fasting or alcohol use, nephrotoxins (aminoglycosides, NSAIDs, iodinated contrast), and hypotension/volume depletion.

Non-modifiable risk factors

• Age, male sex, family history, and inherited enzyme defects.
• Anatomy: watershed zones (splenic flexure, rectosigmoid junction, cortical border zones) and end-arterial supply lack collaterals and die first.
• Prior organ reserve: pre-existing CKD, cirrhosis, or heart failure lowers the injury threshold.

The ATP-depletion cascade (why swelling comes first)

• Loss of oxidative phosphorylation forces anaerobic glycolysis: glycogen is consumed, lactate accumulates, and intracellular pH falls, causing nuclear chromatin clumping.
• Na+/K+-ATPase failure lets sodium and water enter — cellular and organelle swelling, plasma membrane blebbing, and loss of microvilli. All of this is reversible.
• Ribosomes detach from rough ER, halting protein synthesis; the fatty change of early toxic hepatic injury reflects failed apolipoprotein synthesis with continued triglyceride accumulation.

The calcium switch (why injury becomes irreversible)

• Ca2+-ATPase failure plus mitochondrial Ca2+ release raises cytosolic calcium, which activates phospholipase A2 (strips membrane phospholipids), proteases (digest cytoskeleton and membrane proteins), endonucleases (nuclear fragmentation), and additional ATPases (accelerating ATP loss).
• Mitochondrial permeability transition pore opening collapses the proton gradient and is the point of no return; amorphous mitochondrial densities are the ultrastructural correlate.
• Membrane defects release cytosolic contents — troponin, CK-MB, LDH, transaminases, myoglobin, potassium — which is precisely why serum markers exist and why hyperkalemia accompanies massive necrosis.

Classic ischemic necrosis

• Acute coronary syndrome: crushing substernal pressure with diaphoresis, dyspnea, and radiation to jaw or left arm in an older smoker or diabetic; diabetics and women more often present atypically because autonomic neuropathy blunts pain. Pain reflects adenosine and lactate stimulating cardiac afferents, not the necrosis itself.
• Acute ischemic stroke: abrupt focal deficit corresponding to a vascular territory; the deficit is maximal at onset because neurons die within minutes.
• Acute limb or mesenteric ischemia: pain out of proportion to examination, later followed by peritonitis when transmural necrosis occurs.

Systemic signature of necrosis (inflammatory)

• Fever, leukocytosis, and elevated CRP arise because DAMPs released from lysed cells activate innate immunity — this is the key clinical difference from apoptosis, which is clinically silent.
• Hyperkalemia, hyperphosphatemia, and hyperuricemia from released cytosol; peaked T waves on ECG signal danger.

Exposure-defined stems

• Crush injury or prolonged immobilization: muscle tenderness, weakness, and tea-colored urine from myoglobin; the stem names an entrapment, seizure, statin, or cocaine.
• Acetaminophen overdose: nausea only in the first 24 hours, then right upper quadrant pain, transaminases in the thousands at 24–72 hours, coagulopathy and encephalopathy in the worst cases.
• Acute pancreatitis: epigastric pain radiating to the back with Grey Turner and Cullen signs; peripancreatic fat necrosis with saponification can produce hypocalcemia and tetany.
• Tuberculosis: weeks of cough, night sweats, and weight loss, with caseating granulomas underneath.

Step 1 — recognize the syndrome and get the leakage marker

• Chest pain: ECG within 10 minutes plus high-sensitivity cardiac troponin on a serial rise-and-fall pattern. Under the Fourth Universal Definition of Myocardial Infarction, MI requires a troponin value above the 99th percentile upper reference limit with a rise and/or fall, plus ischemic symptoms, ECG changes, imaging evidence, or thrombus — a single elevated troponin means myocardial injury, not infarction. ACC/AHA chest pain guidance endorses hs-troponin rapid rule-out/rule-in pathways.
• Suspected rhabdomyolysis: serum CK markedly elevated (typically many-fold above normal) with a urine dipstick positive for blood but no red cells on microscopy — the classic myoglobinuria clue; check potassium, phosphate, calcium, and creatinine.
• Hepatocellular necrosis: AST/ALT, bilirubin, INR; acetaminophen level plotted on the Rumack–Matthew nomogram for single acute ingestions.
• Global hypoperfusion: lactate and anion gap as surrogates of tissue-level anaerobic metabolism.
• Kidney: KDIGO criteria stage AKI by a creatinine rise of at least 0.3 mg/dL within 48 hours or 1.5 times baseline within 7 days, or urine output below 0.5 mL/kg/h for 6 hours; muddy brown granular casts indicate acute tubular necrosis.

Step 2 — localize with imaging

• MRI diffusion-weighted imaging shows restricted diffusion within minutes of stroke because cytotoxic edema follows Na+/K+-ATPase failure; noncontrast CT is obtained first mainly to exclude hemorrhage (AHA/ASA).
• Contrast-enhanced CT demonstrates non-enhancing pancreatic necrosis; echocardiography shows regional wall-motion abnormality.

Step 3 — histology remains the gold standard

• Coagulative necrosis: preserved tissue outlines with anucleate "ghost" cells; MI evolves from contraction bands and early coagulative change, to neutrophils over the first days, to macrophages, granulation tissue, and finally dense collagenous scar over weeks.
• Apoptosis: cell shrinkage, eosinophilic cytoplasm, pyknotic fragments; confirmed by annexin V binding to externalized phosphatidylserine, TUNEL staining, and internucleosomal DNA laddering (a smear in necrosis).

Immediate stabilization

• Airway, breathing, circulation, and perfusion pressure come first; supplemental oxygen only for hypoxemia, since hyperoxia adds reactive oxygen species. If the patient is in cardiac arrest, follow AHA ACLS — defibrillate the shockable rhythms, ventricular fibrillation and pulseless VT, and give epinephrine 1 mg IV for non-shockable rhythms.
• Treat the lethal electrolyte consequence of necrosis before anything else if ECG changes are present (see the article's supportive measures).

Restore perfusion — the only therapy that saves dying cells

• STEMI: primary PCI is preferred, with a first-medical-contact-to-device target of 90 minutes; fibrinolysis (e.g., tenecteplase) is used when timely PCI is unavailable, per the ACC/AHA acute coronary syndrome guideline, alongside dual antiplatelet therapy and anticoagulation.
• Acute ischemic stroke: IV thrombolysis (alteplase or tenecteplase) within the established time window and mechanical thrombectomy for large-vessel occlusion in selected patients out to 24 hours, per AHA/ASA.

Antidotes and mechanism-specific therapy

• N-acetylcysteine for acetaminophen toxicity — it replenishes glutathione and detoxifies NAPQI; give it early and do not wait for transaminase elevation (AASLD).
• Chelators and enzyme-directed agents: deferoxamine for iron, fomepizole for toxic alcohols, hydroxocobalamin for cyanide.
• Isotonic crystalloid resuscitation for rhabdomyolysis to prevent pigment-induced tubular injury.
• Source control and appropriate antimicrobials for necrotizing infection, with urgent surgical debridement for necrotizing soft-tissue infection (IDSA).

What to avoid

• Thrombolysis with active bleeding, recent intracranial hemorrhage, or other absolute contraindications.
• Nephrotoxins and hypotension in AKI; KDIGO advises against loop diuretics to "treat" established AKI and against low-dose dopamine for renal protection.
• Routine high-dose antioxidant supplements, which lack proven benefit for reperfusion injury in humans.

Emergencies driven by released intracellular contents

• Hyperkalemia: potassium leaves lysed cells; peaked T waves progressing to QRS widening and a sine wave herald arrest. Emergency.
• Pigment-induced acute kidney injury: myoglobin causes tubular obstruction, direct toxicity, and vasoconstriction; signaled by rising creatinine with heme-positive urine lacking RBCs.
• Tumor lysis syndrome after cytotoxic chemotherapy: hyperkalemia, hyperphosphatemia, hyperuricemia, and secondary hypocalcemia with urate/calcium-phosphate nephropathy. Emergency.
• Disseminated intravascular coagulation: necrotic tissue exposes tissue factor; look for thrombocytopenia, prolonged PT/PTT, low fibrinogen, and elevated D-dimer.

Structural sequelae of necrosis, by tissue

• Post-MI mechanical complications: papillary muscle rupture with acute mitral regurgitation, ventricular septal rupture, and free-wall rupture with tamponade — all cluster in the macrophage-rich phase when the infarct is weakest, and all are emergencies. Later come ventricular aneurysm with mural thrombus, heart failure from scar, and Dressler syndrome.
• Brain: cytotoxic edema peaking over the first days can cause midline shift and herniation (emergency); the healed lesion is a fluid-filled cyst with surrounding gliosis and may generate seizures.
• Pancreas: saponification of fat consumes calcium, producing hypocalcemia and tetany; walled-off necrosis may become infected.
• Gut/limb: transmural infarction perforates or requires amputation; reperfusion of ischemic muscle produces compartment syndrome.
• Calcification: dystrophic calcification occurs in already-necrotic tissue with normal serum calcium, versus metastatic calcification in normal tissue when calcium-phosphate product is high.

Treatment-related complications

• Bleeding, including intracranial hemorrhage, after fibrinolysis — the feared emergency of reperfusion therapy.
• Reperfusion arrhythmias and no-reflow phenomenon after PCI.
• Contrast-associated nephropathy after angiography, and anaphylactoid reactions to IV N-acetylcysteine, which are rate-related and usually managed by slowing the infusion.

• Ischemia beats hypoxia for severity: ischemia removes oxygen and substrate and waste clearance, so anaerobic glycolysis cannot compensate. A stem contrasting carbon monoxide poisoning with coronary occlusion is testing exactly this.
• The point of no return is membrane integrity plus the mitochondrial permeability transition pore. Cell swelling and blebbing are reversible; enzyme leak into serum means the membrane is already breached.
• Coagulative necrosis everywhere except the brain, where liquefactive necrosis dominates. Coagulative necrosis preserves the tissue outline because acidosis denatures the lysosomal enzymes that would otherwise digest it.
• Apoptosis discriminators: energy-requiring, non-inflammatory, caspase-mediated, with annexin V positivity from flipped phosphatidylserine and a DNA ladder of internucleosomal fragments — a random smear indicates necrosis.
• The single association most often tested: Bcl-2 overexpression from the t(14;18) translocation in follicular lymphoma blocks the intrinsic pathway, so cells accumulate because they fail to die, not because they divide faster.
• Best next step in an ischemic chest pain stem: ECG within 10 minutes plus serial high-sensitivity troponin, then reperfusion — not advanced imaging first.
• The distractor to refuse: a new left bundle branch block is not a stand-alone STEMI criterion. Apply Sgarbossa criteria (concordant ST elevation, concordant ST depression in V1–V3, or excessively discordant ST elevation) before calling it an infarct.
• Reperfusion is not free: xanthine oxidase, neutrophils, and calcium overload generate reactive oxygen species and contraction band necrosis, extending injury — but the correct answer is still to reperfuse fast, because no antioxidant adjunct has replaced timely PCI or thrombolysis in ACC/AHA and AHA/ASA recommendations.
• Dystrophic calcification occurs in dead tissue with a normal serum calcium; do not choose hypercalcemia as the explanation for calcified atheroma or a calcified caseating granuloma.

• Reversible injury occurs when ATP depletion is mild; irreversible injury results from severe ATP depletion with loss of cell membrane integrity
• Four major pathways of cell death: necrosis, apoptosis, autophagy, pyroptosis
• Necrosis is inflammatory; apoptosis is clean and non-inflammatory
• Ischemia-reperfusion injury causes oxidative stress via free radicals upon reoxygenation
• Apoptosis requires energy (ATP); necrosis does not

• Acute MI with reperfusion: Sudden chest pain with ST elevation; reperfusion causes "reperfusion injury" with additional necrosis beyond ischemic zone
• Apoptosis scenario: Programmed, orderly cell death with apoptotic bodies; seen in normal tissue remodeling, immune selection, and response to mild injury
• Necrosis scenario: Acute pancreatitis with fat necrosis; traumatic brain injury with coagulative necrosis; liquefactive necrosis in brain infarcts
• Drowning/asphyxia: Hypoxic cell injury with cytoplasmic edema progressing to necrosis

MNEMONIC—Reversible Injury Signs (ATP-dependent)

• Cellular swelling
• Organelle swelling (ER, mitochondria)
• Plasma membrane blebs
• Electrolyte imbalance (↑Na+, ↓K+ intracellular)

1. 1.Confusing apoptosis with necrosis: Apoptosis is clean, energy-dependent, and non-inflammatory; necrosis is messy, ATP-independent, and highly inflammatory—test often asks which is "pro-inflammatory"
2. 2.Missing reperfusion injury: Assume ischemia causes all damage; reperfusion actually causes additional ROS-mediated injury—critical in MI, stroke, transplant
3. 3.Forgetting calcium's role: Calcium influx in irreversible injury activates proteases and phospholipases; hyperkalemia from cell death can cause cardiac arrhythmias

• Reversible injury: Restore blood flow, oxygen, and remove offending agent (remove toxin, treat infection)
• Ischemic injury: Rapid reperfusion (thrombolysis/PCI for MI, thrombectomy for stroke) but minimize reperfusion injury with antioxidants and anti-inflammatory measures
• Cell death prevention: Address underlying cause (e.g., antibiotics for sepsis, control HTN in vasculitis)
• Supportive: Manage electrolyte abnormalities (hyperkalemia from cell necrosis via calcium-gluconate, insulin-glucose, beta-agonists)